A global clinical trial for a new Huntington's disease treatment has posted positive results today, announced by trial sponsor uniQure and UCL ...
Ocrevus subcutaneous maintains consistent benefit-risk profile after two years -- New late-breaking data confirms Ocrevus ...
Equities were mixed Wednesday following a down day on Wall Street, where worries about high valuations were compounded by mixed messaging from the Federal Reserve on its plans for interest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback